The short version
- Why people research itUpstream stimulation of the reproductive hormone axis (LH/FSH, testosterone).
- What the evidence isGenuine human trials, mostly out of Imperial College London.
- What to watchIrregular cycles or loss of periods.
How Kisspeptin works
Hypothalamic peptide that stimulates GnRH release, driving LH/FSH and downstream testosterone — upstream of the whole HPG axis.
Kisspeptin sits one step upstream of everything the gonadorelin page is about, and that single positional fact is the whole argument for it. A GnRH agonist acts on the pituitary and can therefore desensitize the pituitary.
The peptide and the receptor. The KISS1 gene product is processed to a 54-residue peptide and to shorter C-terminal fragments; the decapeptide kisspeptin-10 retains full activity and is what is usually studied. It is an RFamide — the C-terminus is arginine-phenylalanine-amide, and that motif is what the receptor reads.
- Injectable
Research on Kisspeptin5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
Genuine human trials, mostly out of Imperial College London. Kisspeptin-54 infusion reliably triggers LH and FSH release in men and women, and has been trialed as a trigger for oocyte maturation in IVF — where it produced substantially less ovarian hyperstimulation syndrome than the standard hCG trigger, which is a real clinical advantage.
Further trials showed effects on limbic brain activity and sexual response in men with hypoactive sexual desire.
Correlative data
Limited community use relative to its evidence base.
How the mechanism reads
Kisspeptin sits upstream of the entire reproductive axis — it drives GnRH release, which drives LH and FSH, which drive testosterone or estrogen. It is the master switch, and loss-of-function mutations cause failure to enter puberty.
MechanisticActing that far upstream predicts the appeal and the limit: the whole axis stays under its own feedback control, and a very short half-life means continuous administration paradoxically desensitizes the system rather than driving it harder.
Mechanistic
Sources
- Koysombat K, et al. Kisspeptin and Neurokinin B: roles in reproductive health. Physiological Reviews 2025 · PMID 39813600
- Patel B, et al. The emerging therapeutic potential of kisspeptin and neurokinin B. Endocrine Reviews 2023 · PMID 37467734
- Pierret ACS, et al. Kisspeptin as a test of hypothalamic dysfunction in pubertal and reproductive disorders. Andrology 2025 · PMID 39834030
- Mills EG, et al. Invited review: Translating kisspeptin and neurokinin B biology into new therapies for reproductive health. Journal of Neuroendocrinology 2022 · PMID 36262016
- Hu KL, et al. Advances in clinical applications of kisspeptin-GnRH pathway in female reproduction. Reproductive Biology and Endocrinology 2022 · PMID 35606759
- Jayasena CN, et al. Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men. Human Reproduction 2015 · PMID 26089302
Kisspeptin safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Hormone-sensitive cancer, as it drives LH, testosterone and estradiol.
- Pregnancy, where kisspeptin drives placental and gonadal hormone release.
- Polycystic ovary syndrome, where LH is often already high.
- Precocious or early puberty.
- Using a long-acting form that could desensitize the GnRH receptor.
What’s expected
- LH rises within minutes via GnRH neurons.
- Testosterone or estradiol follows.
- Continuous exposure desensitizes the axis.
Watch for
- Irregular cycles or loss of periods.
- Breast tenderness.
- Falling libido, which signals the axis went quiet.
Labs that tell you it’s working
- LH & FSH: the direct readout of hypothalamic drive.
- Total & Free Testosterone: the downstream effect in men.
- Estradiol: the downstream effect in women and aromatization in men.
Hypothalamic peptide that stimulates GnRH release upstream of the whole HPG axis; not approved anywhere, human data come from research studies. PMID 39813600 PMID 37467734 PMID 39834030
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
The “Low T? Rule Out the Reversible Causes First” panel, explained
Kisspeptin FAQ4 common questions
- Is Kisspeptin approved for human use?
- No. Kisspeptin is a research compound.
- What is Kisspeptin researched for?
- Upstream stimulation of the reproductive hormone axis (LH/FSH, testosterone).
- Which labs show whether it's doing anything?
- LH & FSH; Total & Free Testosterone; Estradiol: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Kisspeptin: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.




